Validating a clinical prediction score for Legionella-related community acquired pneumonia

Legionella-related community acquired pneumonia (CAP) is a disease with an increasing incidence and a high mortality rate, especially if empirical antibiotic therapy is inadequate. Antibiotic treatment highly relies on clinical symptoms, although proven non-specific, because currently available diag...

Full description

Bibliographic Details

Published in:	BMC infectious diseases 2022-05, Vol.22 (1), p.442-442, Article 442
Main Authors:	Beekman, Rosalie R A L, Duijkers, Ruud R, Snijders, Dominic D, van der Eerden, Menno M, Kross, Martijn M, Boersma, Wim W G
Format:	Article
Language:	eng
Subjects:	Accuracy Anti-Bacterial Agents - therapeutic use Antibiotics Antigens C-reactive protein Clinical prediction rule Community-acquired infections Community-Acquired Infections - diagnosis Community-Acquired Infections - drug therapy Community-acquired pneumonia Complications and side effects Cough Diagnostic systems Dosage and administration Drug therapy Empirical analysis Fever Health risk assessment Health services Humans Hyponatremia Immune system L-Lactate Dehydrogenase Lactate dehydrogenase Lactic acid Legionella Legionella pneumophila Legionellosis Legionnaires' disease Legionnaires' Disease - diagnosis Legionnaires' Disease - drug therapy Methods Mortality Pathogens Patients Pneumonia Pneumonia - diagnosis Pneumonia - drug therapy Predictions Prognosis Rapid diagnosis Regression analysis Risk factors Risk factors (Health) Signs and symptoms Streptococcus infections Teaching hospitals
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!